Sort by
Refine Your Search
-
undergone in the murine model using an experimental influenza vaccine that has already been developed in our laboratory using antigens derived from the H1N1/PR8 influenza strain. Candidate profile: We
-
immunotherapy interventions targeting CD4+ T cells based on recombinant monoclonal antibodies or mRNA-containing lipid nanoparticles. The project will be primarily developed in a pre-clinical murine model of lung
Searches related to local development
Enter an email to receive alerts for local-development positions